SEC Form 4 · accession 0001140361-16-075986
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brett Sandercock
Officer — Chief Financial Officer
Period of report
Aug 11, 2016
Accepted (ET)
Aug 11, 2016 · 7:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1,F2,F3 | Aug 11, 2016 | S | 35,000 | $70.50 | D | 51,084 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $70.22 to $70.79. The price reported above reflects the weighted average sale price.
- F2Restated balance to correct duplicate reporting of 33,473 shares vested 11/11/2014.
- F3Includes 229.81 shares of ResMed stock purchased on May 5, 2016, through the ResMed Employee Stock Purchase Plan.